Healthcare

Kardigan filed an 8-K on September 30, 2026 disclosing that Kristin Reinke joined its board as a Class I director on September 29, 2026 and will chair the Audit Committee. She is Vice President of Finance at Google, holds a CPA, and the board …

Ginkgo Bioworks (NYSE:DNA) closed at USD 14.98 on October 5, 2026, up 21.3 percent from USD 12.35, after opening at USD 12.50 and touching USD 15.48, according to published market data. About 7.5 million shares changed hands against roughly 2.0 million the prior session. …

Iovance Biotherapeutics (NASDAQ:IOVA) jumped 31.5 percent on September 29, 2026, closing at USD 14.45 from USD 10.99 onVolumeof about 78 million shares against roughly 12 million on a typical day. The catalyst was a raised outlook. Reported 2026 total revenue guidance rose to USD …

Published market data put Quanterix (NASDAQ:QTRX) at USD 3.64 at the October 2, 2026 close, and a stub circulating for this topic reported a 6.74 percent gain that day. The stub's headline claim of a 7.1 percent decline could not be matched to any …

Spyre announced a proposed underwritten public offering of common stock on October 5, 2026, then priced it at USD 85.00 a share for gross proceeds of about USD 350.0 million, according to the company release. That equals 4,117,648 shares. Underwriters hold a 30-day option …

Published market data show Tempus AI (NASDAQ:TEM) closed up 9.03 percent on October 5, 2026, extending a rebound from a mid-September low near USD 58.74, as reported. A second market data page put the day's close near USD 81.65, so the exact level conflicts …

Published market data show Twist Bioscience (NASDAQ:TWST) opening at USD 193.46, reaching USD 207.90 and closing at USD 205.00 on October 5, 2026, up 8.7 percent from USD 188.67. That compares with a close of USD 164.60 on September 22, a gain of about …